Skip to main content
Premium Trial:

Request an Annual Quote

FDA Seeks Microarray Datasets for Quality Control Project

NEW YORK, April 21 (GenomeWeb News) - the US Food and Drug Administration is soliciting gene expression datasets from microarray experiments as part of its MicroArray Quality Control project.


In a notice of solicitation dated April 13 and posted on the FDA website yesterday, FDA said that it is seeking datasets "as well as proposals to analyze these datasets in order to evaluate the impact of different analysis protocols on the selection of genes and their associated signatures for biomarker pattern development."


The FDA's NationalCenter for Toxicological Research is collecting the datasets and proposals for participation in the project. The evaluation process is open to the public, FDA said.


The MAQC project involves six FDA centers, several microarray vendors, government agencies, and academic labs that are working to develop "baseline practices for the analysis of hybridization data," the FDA said.


Further information on the MAQC project is available here.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.